Eszter Regos
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Sample adequacy in bronchoscopic ROSE: comparison between laboratory specialist and pathologist.
Journal: Pathology oncology research : POR
Published: November 20, 2025
Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18 F-FDG-PET/CT images.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 25, 2025
Association of Meconium-Stained Amniotic Fluid and Histological Chorioamnionitis with Fetal Inflammatory Response in Preterm Deliveries.
Journal: Children (Basel, Switzerland)
Published: February 10, 2025
Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations.
Journal: Molecular oncology
Published: July 15, 2024
Syndecan-1 in liver pathophysiology.
Journal: American journal of physiology. Cell physiology
Published: June 15, 2022
EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study.
Journal: Translational lung cancer research
Published: March 15, 2021
The Protective Role of Decorin in Hepatic Metastasis of Colorectal Carcinoma.
Journal: Biomolecules
Published: June 30, 2020
Chronic Hyperglycaemia Induced Alterations of Hepatic Stellate Cells Differ from the Effect of TGFB1, and Point toward Metabolic Stress.
Journal: Pathology oncology research : POR
Published: July 06, 2018
Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: November 15, 2017
Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor.
Journal: Pathology oncology research : POR
Published: March 30, 2016
Last Updated: 09/26/2026